# K951802: Scimed Encore Advantage Kit and the Essentials Kit

- Pathway: 510(k) (Traditional)
- Applicant: Scimed Life Systems, Inc.
- Decided: Jul 21, 1995 after 93 days
- Product code: DXT (Injector And Syringe, Angiographic)
- Device class: 2
- Regulation: 21 CFR 870.1650
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
6 later devices descend from it; 1 cites it directly.
0 of 7 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA has not posted a summary or statement for it, so its predicates are not known.

## Most influential descendants
- K120694: Encore 26 Advantage Kit (2012), 5 descendants of its own
- K123214: Encore 26 Advantage Kit (2012), 3 descendants of its own
- K140673: Insertion Tool (2014), 1 descendant of its own
- K172453: WATCHDOG Hemostasis Valve Kit (2017), 0 descendants of its own
- K140745: Encore 26 Advantage Kit (2014), 0 descendants of its own

Source page: https://510kreport.com/device/K951802
Methodology: https://510kreport.com/methodology